Maik GollaschStructure of the GroupGroup LeaderProf. Maik GollaschGraduate students andclinical fellowsJohanna SchleifenbaumCarolin KöhnMirija WechslerMarwan MannaaDr. Alexander WutzlerAssociated scientistsDr. Kirill EssinDr. Galyna DubrovskaTechnical AssistantsYoland-Marie AnistanDiana HeroldManager of sponsoredprogramsSusanne WisslerSmooth Muscle Cell Electrophysiology,Ion Channel, and Transporter FunctionIon channels and electrophysiologyThis group focuses on ion channels, primarily in vascularsmooth muscle cells (VSMC), to clarify mechanismscontributing to hypertension and cardiovascular disease.Calcium-activated potassium (BK) channels havereceived special attention. The group collaborated withRalph Kettritz to study the notion that BK channels areinvolved in neutrophil activation. A knockout mousemodel showed convincingly that BK channels are notinvolved in this process. The group investigated the roleof transient receptor potential (TRP) ion channels inagonist-independent G(q 11) protein-coupled receptoractivation. Their work showed that G(q 11)-coupledreceptors could function as membrane stretch receptorsin VSMC. A close collaboration with Wolf-HagenSchunck at the <strong>MDC</strong> has turned the group’s focustowards eicosanoids. The group found that p450eicosanoids such as epoxyeicosatrienoic acids arevasodilatory, largely through their ability to activateendothelial NO synthase and NO release. Furthermore,in collaboration with Huang Yu in Hong Kong, theyfound that endothelium-derived contracting factors aredependent on cyclooxygenase-2. Another area ofresearch is directed towards identifying the role of theperivascular fat as a modulator of arterial tone, withspecific emphasis on the resistance vasculature.BK channels and neutrophil functionThe group (in collaboration with Ralph Kettritz (ECRC)and William Nauseef (University of Iowa) was involvedin an “intensive” controversy with a group at UniversityCollege London, regarding the importance of BK channelsin the mediation of neutrophil “burst” reactions. Totest this notion, Kirill Essin and the group directlyassessed the role of BK channels in neutrophil function,including the NADPH oxidase. Neutrophils lacking BKchannels (BK-/-) had normal intracellular and extracellularNADPH oxidase activity in response to both receptor-independentand phagocytic challenges. Furthermore,NADPH oxidase activity of neutrophils andmacrophages was normal after treatment with BKchannel inhibitors. Although BK channel inhibitors suppressedendotoxin-mediated tumor necrosis factoralphasecretion by bone marrow-derived macrophages,cells from BK-/- and wild-type mice responded identicallyand exhibited the same ERK, PI3K/Akt, and NF-κBactivation. The group concluded that the BK channel isnot required for NADPH oxidase activity in neutrophils.The contentious argument has been dropped.Epoxyeicosatrienoic acids (EETs)EETs serve as endothelial-derived hyperpolarizing factors(EDHF), but may also affect vascular function byother mechanisms. The Gollasch team identified anovel interaction between EETs and endothelial NOrelease using soluble epoxide hydrolase (sEH) -/- and+/+ mice. EDHF responses to acetylcholine in pressurizedisolated mesenteric arteries were neither affectedby the sEH inhibitor, N-adamantyl-N’-dodecylurea(ADU), nor by sEH gene deletion. However, the EDHFresponses were abolished by catalase and byapamin/charybdotoxin (ChTx), but not by iberiotoxin,nor by the cytochrome P450 inhibitor PPOH. All fourEETs (order of potency: 8,9-EET >14,15-EET approximately5,6-EET >11,12-EET) and all 4 dihydroxy derivatives(14,15-DHET approximately 8,9-DHET approximately11,12-DHET >5,6-DHET) produced dose-dependentvasodilation. Endothelial removal or L-NAME blocked8,9-EET and 14,15-DHET-dependent dilations. Theeffects of apamin/ChTx were minimal. 8,9-EET and14,15-DHET induced NO production in endothelial cells.ADU (100 µg/ml in drinking water) lowered blood pres-214 The Experimental and Clinical <strong>Research</strong> Center
Epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoicacids (DHETs) stimulate the productionof nitric oxide (NO) in endothelial cellsto induce vasorelaxation. Red blood cells are arich source of EETs and may utilize this mechanismto produce vasorelaxation in the microcirculation(from the cover page of ArteriosclerThromb Vasc Biol. 2009 Jan;29(1)).sure in angiotensin II-infused hypertension, but not inL-NAME-induced hypertension. Blood pressure andEDHF responses were similar in L-NAME-treated sEH+/+ and -/- mice. The data indicate that the EDHFresponse in mice is caused by hydrogen peroxide, butnot by P450 eicosanoids. Moreover, P450 eicosanoidsare vasodilatory, largely through their ability to activateendothelial NO synthase (eNOS) and NO release.Endothelial-derived contracting factors (EDCFs)Hypertension and vascular dysfunction result in theincreased release of EDCFs, whose identity is poorlydefined. The Gollasch team tested the hypothesis thatendothelial cyclooxygenase (COX)-2 can generateEDCFs and identified the possible EDCF candidate. Theyshowed that endothelium-dependent contractionswere triggered by acetylcholine (ACh) after inhibitionof nitric oxide production and they were abolished byCOX-2 but not COX-1 inhibitors or by thromboxaneprostanoidreceptor antagonists. The cation channelblocker, 2-amino-ethoxydiphenyl borate eliminatedendothelium-dependent contractions and ACh-stimulatedrises in endothelial cell [Ca(2+)](i). RT-PCR andWestern blotting showed COX-2 expression mainly inthe endothelium. Enzyme immunoassay and high-performanceliquid chromatography-coupled mass spectrometryshowed release of prostaglandin(PG)F(2alpha) and prostacyclin (PGI(2)) increased byACh; only PGF(2alpha) caused contraction at relevantconcentrations. COX-2 expression, ACh-stimulated contractions,and vascular sensitivity to PGF(2alpha) wereaugmented in aortae from aged hamsters. Humanrenal arteries also showed thromboxane-prostanoidreceptor-mediated ACh- or PGF(2alpha)-induced contractionsand COX-2-dependent release of PGF(2alpha).The results support a critical role of COX-2 in endothelium-dependentcontractions in this species with anincreased importance during aging and, possibly, asimilar relevance in humans.Selected publicationsEssin, K, Gollasch, M, Rolle, S, Weissgerber, P, Sausbier, M, Bohn, E,Autenrieth, IB, Ruth, P, Luft, FC, Nauseef, WM, Kettritz, R. (2009) BKchannels in innate immune functions of neutrophils and macrophages.Blood. 113, 1326-1331.Hercule, HC, Schunck, WH, Gross, V, Seringer, J, Leung, FP, Weldon, SM, daCosta Goncalves, ACh, Huang, Y, Luft, FC, Gollasch, M. (2009) Interactionbetween P450 eicosanoids and nitric oxide in the control of arterial tonein mice. Arterioscler Thromb Vasc Biol. 29, 54-60.Wong, SL, Leung, FP, Lau, CW, Au, CL, Yung, LM, Yao, X, Chen, ZY, Vanhoutte,PM, Gollasch, M, Huang, Y. (2009) Cyclooxygenase-2-derived prostaglandinF2alpha mediates endothelium-dependent contractions in theaortae of hamsters with increased impact during aging. Circ Res. 104,228-35.Hegner, B, Lange, M, Kusch, A, Essin, K, Sezer, O, Schulze-Lohoff, E, Luft, FC,Gollasch, M, Dragun, D. (2009) mTOR regulates vascular smooth musclecell differentiation from human bone marrow-derived mesenchymalprogenitors. Arterioscler Thromb Vasc Biol. 29, 232-238.Mederos, Y, Schnitzler, M, Storch, U, Meibers, S, Nurwakagari, P, Breit, A,Essin, K, Gollasch, M, Gudermann, T. (2008) Gq-coupled receptors asmechanosensors mediating myogenic vasoconstriction. EMBO J. 27,3092-3103.The Experimental and Clinical <strong>Research</strong> Center 215
- Page 1:
Research Report 2010MAX DELBRÜCK C
- Page 4 and 5:
ContentInhaltContentInhalt.........
- Page 6 and 7:
Surgical OncologyPeter M. Schlag...
- Page 11 and 12:
at the MDC. The role of the institu
- Page 13 and 14:
in discovering genes that contribut
- Page 16 and 17:
The ECRC offers research space and
- Page 18 and 19:
etween disciplines such as biology,
- Page 20 and 21:
approaches from bioinformatics/syst
- Page 23 and 24:
von Humboldt Foundation (AvH). The
- Page 25:
organization to a larger, multi-fac
- Page 28 and 29:
Cardiovascular and Metabolic Diseas
- Page 30 and 31:
electrical signals. More recent wor
- Page 32 and 33:
Basic Cardiovascular FunctionStruct
- Page 34 and 35:
Figure 2: SORLA and sortilin in neu
- Page 36 and 37:
Annette Hammes(Delbrück Fellow)Str
- Page 38 and 39:
Ingo L. MoranoStructure of the Grou
- Page 40 and 41:
Figure 3. Membrane resealing assay
- Page 42 and 43:
Michael GotthardtStructure of the G
- Page 44 and 45:
Structure of the GroupSalim Seyfrie
- Page 46 and 47:
Structure of the GroupFerdinand le
- Page 48 and 49:
Francesca M. SpagnoliStructure of t
- Page 50 and 51:
Structure of the GroupKai M. Schmid
- Page 52 and 53:
Genetics and Pathophysiology of Car
- Page 54 and 55:
Figure 2. Planariato experimentally
- Page 56 and 57:
Norbert HübnerStructure of the Gro
- Page 58 and 59:
Structure of the GroupGroup LeaderF
- Page 60 and 61:
Figure 2. Omega-3 fatty acids prote
- Page 62 and 63:
Structure of the GroupDominik N. M
- Page 64 and 65:
Rainer DietzStructure of the GroupG
- Page 66 and 67:
Figure 2. Cardiac-restricted ablati
- Page 68 and 69:
Ludwig ThierfelderStructure of the
- Page 70 and 71:
standing of the molecular and cellu
- Page 72 and 73:
Structure of the GroupThoralf Niend
- Page 74 and 75:
Michael BaderStructure of the Group
- Page 76 and 77:
Natriuretic peptide systemJens Butt
- Page 78 and 79:
Structure of the GroupZsuzsanna Izs
- Page 80 and 81:
Young-Ae LeeStructure of the GroupG
- Page 82 and 83:
Structure of the GroupMatthias Selb
- Page 84 and 85:
Matthew PoyStructure of the GroupGr
- Page 86 and 87:
Jana WolfStructure of the GroupGrou
- Page 88 and 89:
Structure of the GroupGroup LeaderD
- Page 91 and 92:
Cancer Research ProgramKrebsforschu
- Page 93 and 94:
are responsible for the emergence o
- Page 95 and 96:
tral component of the canonical Wnt
- Page 97 and 98:
lead to an aberrant constitutive ac
- Page 99 and 100:
How Notch- and TGFβ signaling casc
- Page 101 and 102:
tures of the chronic phase in human
- Page 103 and 104:
oped a new safeguard that is based
- Page 105 and 106:
Graduate StudentsSeda Cöl ArslanCa
- Page 107 and 108:
investigation, as is the cause of c
- Page 109 and 110:
Graduate StudentsÖzlem Akilli Özt
- Page 111 and 112:
onment, the (cancer) stem cell nich
- Page 113 and 114:
The pluripotent state of murine and
- Page 115 and 116:
In the morula of the early mouse em
- Page 117 and 118:
Graduate StudentsRami Hamscho*Qingb
- Page 119 and 120:
esis and granulopoiesis. We showed
- Page 121 and 122:
URE ∆/∆ mice regularly develope
- Page 123 and 124:
PD Dr. Wolfgang Walther (GroupLeade
- Page 125 and 126:
For the delivery of naked DNA into
- Page 127 and 128:
ACBDMyc and FoxO transcription fact
- Page 129 and 130:
Graduate StudentsKatrin BagolaHolge
- Page 131 and 132:
Heinemann, we could also identify t
- Page 133 and 134:
Above: Tip of chromosom3L showing t
- Page 135 and 136:
Graduate StudentsSarbani Bhattachar
- Page 137 and 138:
vesicle transport to the Golgi. Our
- Page 139 and 140:
acbFigure 1a: EHD2 is tubulatingpho
- Page 141 and 142:
KnowledgeProbabilitiesknownPossible
- Page 143 and 144:
Graduate and undergraduatestudentsU
- Page 145 and 146:
successive oncogenic mutations. We
- Page 147 and 148:
CXCR5 drives the development of ect
- Page 149 and 150:
Graduate and undergraduatestudentsW
- Page 151 and 152:
Graduate andUndergraduate StudentsM
- Page 153 and 154:
Angela MensenStefanie WittstockBjö
- Page 155 and 156:
deficient mice, both major effector
- Page 157 and 158:
ant of CD3 delta coding for a 45-me
- Page 159 and 160:
Robert KudernatschLi-Min LiuAna Mil
- Page 161 and 162:
Sebastian GüntherTechnical Assista
- Page 163 and 164:
Graduate StudentsJana RolffAnnika W
- Page 165:
with murine hepatocytes showed morp
- Page 168 and 169:
Function and Dysfunction of the Ner
- Page 170 and 171:
The Neuroscience Department also es
- Page 172 and 173:
the coming years, Björn Schröder
- Page 174 and 175:
mice. Further analysis of the funct
- Page 176 and 177:
Signaling Pathways and Mechanisms i
- Page 178 and 179:
Control Olig3 -/-ABFigure 2. Geneti
- Page 180 and 181:
Thomas J. JentschStructure of the G
- Page 182 and 183:
Figure 2. Cellular model for ionic
- Page 184 and 185:
Structure of the GroupGroup LeaderF
- Page 186 and 187:
paired-pulse facilitation, less dep
- Page 188 and 189:
Gary R. LewinStructure of the Group
- Page 190 and 191: Model summarizing the three waves o
- Page 192 and 193: Structure of the GroupInes Ibañez-
- Page 194 and 195: Jochen C. MeierStructure of the Gro
- Page 196 and 197: Björn Christian SchroederStructure
- Page 198 and 199: Structure of the GroupJan Siemens(S
- Page 200 and 201: Structure of the GroupGroup LeaderD
- Page 202 and 203: Imaging of the Living BrainStructur
- Page 204 and 205: Pathophysiological Mechanisms of Ne
- Page 206 and 207: Figure 2. Iba1 positive microglia c
- Page 208 and 209: Erich E. WankerStructure of the Gro
- Page 210 and 211: Scientific-Technical StaffAnja Frit
- Page 212 and 213: Structure of the GroupJan Bieschke(
- Page 215 and 216: Berlin Institute of Medical Systems
- Page 217 and 218: etes, metabolic diseases and neurod
- Page 219 and 220: A number of MDC investigators have
- Page 221 and 222: Technical AssistantsClaudia Langnic
- Page 223 and 224: has become a standardized data flow
- Page 225: Phylogeny of cellulase genes from P
- Page 228 and 229: Experimental and Clinical Research
- Page 230 and 231: his patients, and a basic research
- Page 232 and 233: The ultrahigh field MR facility was
- Page 234 and 235: Structure of the GroupSimone Spuler
- Page 236 and 237: Ralph KettritzStructure of the Grou
- Page 238 and 239: Structure of the GroupJeanette Schu
- Page 243 and 244: Technology PlatformsComputational B
- Page 245 and 246: projects/ard/] to detect repeats li
- Page 247 and 248: Simulation of line-scan images of C
- Page 249 and 250: Development of an MRM method for qu
- Page 251 and 252: mobility or turnover of the underly
- Page 253 and 254: Left: Inside view of a FACSAria2 (f
- Page 255 and 256: Examples fort the use of EM methods
- Page 257: Oviducts lined up in pre-implantati
- Page 260 and 261: Academic Appointments 2008-2009Beru
- Page 262 and 263: Buch which is part of the Excellenc
- Page 264 and 265: “Bioinformatics in Quantitative B
- Page 266 and 267: Delbrück FellowsDelbrück-Stipendi
- Page 268 and 269: Yinth Andrea Bernal-Sierra, a PhD s
- Page 270 and 271: Congresses and Scientific MeetingsK
- Page 272 and 273: SeminarsSeminare2008Speaker Institu
- Page 274 and 275: Speaker Institute TitleKiyoshi Mori
- Page 276 and 277: 2009Speaker Institute TitleDavid G.
- Page 278 and 279: Speaker Institute TitleJuri Rappsil
- Page 280 and 281: The Helmholtz AssociationDie Helmho
- Page 282 and 283: The Berlin-Buch CampusDer Campus Be
- Page 284: the MDC, the existing collaboration
- Page 287 and 288: Prof. Dr. Gary R. LewinMDC Berlin-B
- Page 289 and 290: Prof. Dr. Renato ParoCenter of Bios
- Page 291 and 292:
Staff CouncilThe Staff Council is i
- Page 293 and 294:
Type of Financing/Art der Finanzier
- Page 295 and 296:
Research Projects 2008-2009Forschun
- Page 297 and 298:
CIC-5 Regulation und Endocytose am
- Page 299 and 300:
MDCMAX-DELBRÜCK-CENTRUMFÜR MOLEKU
- Page 301 and 302:
Index 275Bröske, A. . . . . . . .
- Page 303 and 304:
Index 277Gross, V. . . . . . . . .
- Page 305 and 306:
Index 279Kur, E. . . . . . . . . .
- Page 307 and 308:
Index 281Piano, F. . . . . . . . .
- Page 309 and 310:
Index 283Smink, J. . . . . . . . .
- Page 312 and 313:
Campus MapCampusplanRobert-Rössle-
- Page 314:
How to find your way to the MDCDer